Group 1 - The core viewpoint of the report is that China Longjiang Infrastructure Group is expected to achieve a net profit growth of 2% year-on-year to HKD 8.27 billion in 2025, which is stable and in line with market expectations [1] - The company has increased its dividend for 29 consecutive years, with an annual dividend of HKD 2.61, representing a year-on-year increase of 1.2%, and a payout ratio of 80%, resulting in a dividend yield of 4% [1] - The report suggests that China Longjiang Infrastructure provides a safe haven for investors amid current macroeconomic volatility, as the group holds ample cash after asset sales, maintains stable dividend distributions, and benefits from regulatory resets [1] Group 2 - The firm maintains an "outperform" rating for China Longjiang Infrastructure, with a target price set at HKD 63 [1]

Group 1 - The A-share market has seen a rise in certain chemical stocks, with Xinghua Co. hitting the daily limit, Guofa Co. increasing by over 3%, and several others like Xin'ao Co., Guanghui Energy, Donghua Energy, Dawi Technology, and Shengli Co. rising by over 2% [1] - BASF, the world's largest chemical giant, announced a price increase of 30% or more for all household care, industrial, and institutional cleaning and industrial formulation products in Europe starting March 18. This decision is in response to significant fluctuations in key raw material prices and supply, rising domestic and cross-continental logistics costs, and soaring packaging and energy costs [1] - BASF also stated that it would increase its formic acid sales price in Europe by €250 per ton and the price of neopentyl glycol by €350 per ton, effective immediately or as allowed by existing contracts [1] Group 2 - Xinghua Co. has a market capitalization of 6.739 billion, with a year-to-date increase of 48.73% [2] - Guofa Co. has a market capitalization of 3.313 billion, with a year-to-date increase of 3.27% [2] - Xin'ao Co. has a market capitalization of 70.2 billion, with a year-to-date increase of 9.20% [2] - Guanghui Energy has a market capitalization of 44.7 billion, with a year-to-date increase of 42.07% [2] - Donghua Energy has a market capitalization of 1.47 billion, with a year-to-date increase of 15.06% [2] - Dawi Technology has a market capitalization of 17.3 billion, with a year-to-date increase of 62.43% [2] - Shengli Co. has a market capitalization of 4.471 billion, with a year-to-date increase of 1.39% [2]

Core Viewpoint - UBS report indicates that Fuyao Glass is expected to achieve a revenue growth of 16.7% year-on-year to 45.79 billion yuan by 2025, driven by an 8.5% increase in automotive glass sales and an 8.1% rise in average price per square meter [1] Financial Performance - The company's net profit is projected to grow by 24.2% year-on-year to 9.31 billion yuan by 2025 [1] - In Q4, revenue reached 12.49 billion yuan, reflecting a year-on-year increase of 14.1%, while net profit was 2.25 billion yuan, up 11.4% year-on-year [1] - Gross margin decreased by 0.9 percentage points to 37% quarter-on-quarter, primarily due to additional price adjustments and the impact of local automotive market fluctuations in the U.S. [1] Forecast Adjustments - Due to underperformance in the domestic automotive market and potential cost increases from the Middle East conflict, UBS has lowered its profit forecasts for 2026 to 2028 by 4% [1] - The target price for Fuyao Glass has been revised down from 96 HKD to 93 HKD, while maintaining a "Buy" rating [1]

Group 1 - The core viewpoint of the articles highlights a significant rise in coal stocks in Hong Kong, driven by escalating geopolitical tensions in the Middle East, which have led to increased oil prices and heightened demand for coal as an energy alternative [1][2] - Yancoal Australia saw a rise of over 6%, while Yanzhou Coal Mining and China Shenhua Energy increased by over 4% and 3.2% respectively, approaching historical highs [1][2] - Newcastle coal futures jumped by 9.3% in March, reaching $150 per ton, indicating a strong market response to external shocks and reinforcing the sentiment in coal stocks [1] Group 2 - Brent crude oil prices rose by 5.7% and further increased by over 3% to $107.2, marking a new high since March 9, due to attacks on oil facilities in the region [1] - The report from Founder Securities suggests that if geopolitical conflicts persist, coal prices may rise, supported by rigid supply and demand dynamics, which could enhance long-term valuations [1]

Group 1 - Coal stocks in Hong Kong have risen against the trend, with Yancoal Australia leading the increase by over 6%, Yanzhou Coal Mining up over 4%, and China Shenhua Energy rising by 3.2%, all approaching historical highs [1] - The ongoing escalation of the Middle East situation has driven up oil prices, with Brent crude oil rising by 5.7% yesterday and over 3% today to reach $107.2, the highest since March 9 [1] - Newcastle coal futures jumped by 9.3% in March, reaching $150 per ton, indicating an increased demand for coal as an energy alternative due to external shocks [1] Group 2 - The stock performance of key coal companies is as follows: Yancoal Australia at $45.520 with a 6.49% increase, Yanzhou Coal Mining at $16.630 with a 4.26% increase, China Shenhua Energy at $48.980 with a 3.20% increase, Power Development at $2.290 with a 2.69% increase, and China Coal Energy at $14.480 with a 2.55% increase [2]

Core Insights - The GTC 2026 conference highlighted the emergence of physical AI, with NVIDIA's CEO Jensen Huang stating that the "ChatGPT moment for physical AI has arrived" as machines begin to understand, reason, and act in the real world [1] Group 1: Product Launch and Features - Lenovo Group launched the Auto AI Box, a vehicle AI computing platform designed to integrate into existing automotive systems without requiring a complete redesign of the vehicle's electronic architecture [1] - The Auto AI Box is built on the NVIDIA DRIVE AGX Thor platform and utilizes Lenovo's expertise in automotive-grade hardware, featuring the agentic AI operating system FusionOS 4.0 to run multimodal large models locally within vehicles [1] - The platform supports natural language interaction and can operate models with parameter scales up to 13 billion (13B), providing robust and scalable computing power for in-vehicle AI applications [1] Group 2: Market Implications and Strategic Positioning - The introduction of the Auto AI Box allows automotive companies to quickly implement multimodal interaction, edge reasoning, and in-vehicle intelligent services, thereby shortening the development to deployment cycle [2] - Lenovo's move aligns with the clear signal from GTC 2026 that physical AI is transitioning from a supplementary function to a foundational capability in automotive infrastructure [2] - Lenovo is focusing on the transformation of vehicles into intelligent terminals rather than traditional vehicle manufacturing, aiming to secure a position in the next generation of smart mobility infrastructure with the Auto AI Box [2]

格隆汇3月19日丨和誉-B(02256.HK)发布公告，公司的附属公司上海和誉生物医药科技有限公司("和誉 医药")宣布，其自主研发的高选择性口服小分子FGFR2/3抑制剂ABSK061已获得美国食品药品监督管理 局("FDA")授予的孤儿药资格认定("ODD")，用于治疗软骨发育不全("ACH")。这是ABSK061近期获得 FDA授予罕见儿科疾病("RPD")资格认定后，在其全球开发进程中的又一关键里程碑。ODD有望为该产 品在美国的临床开发、注册申报与商业化进程提供有力支持。 ...

Core Insights - Geely Automobile Holdings Limited reported a record total revenue of 345.2 billion yuan for 2025, representing a 25% year-on-year increase, with core net profit rising by 36% to 14.41 billion yuan, indicating high-quality growth [1] - The company achieved a total sales volume of 3.025 million vehicles in 2025, a 39% increase, exceeding its adjusted target of 3 million units [1] - Geely's cash reserves increased by 46% to 68.2 billion yuan, allowing for a proposed dividend increase of 51.5% to 0.5 HKD per share [1] Revenue and Profit Growth - Total revenue reached 345.2 billion yuan, a 25% increase year-on-year, marking a historical high [1] - Core net profit after excluding foreign exchange impacts was 14.41 billion yuan, up 36% year-on-year, indicating a higher growth rate than revenue [1] - Gross profit increased to 57.3 billion yuan, also a 25% year-on-year rise [1] Sales Performance - Total vehicle sales reached 3.025 million units, a 39% increase, surpassing the revised target of 3 million units [1] - New energy vehicle sales exceeded 1.68 million units, a significant 90% increase, placing Geely among the top tier in new energy development [1] - In the first two months of 2026, Geely sold 476,000 vehicles, maintaining the industry's leading position [1] Brand Strategy and Market Positioning - The "One Geely" strategy was further deepened, integrating Zeekr and enhancing brand positioning across mainstream, high-end, and luxury markets [3] - Zeekr brand sales surpassed 224,000 units in 2025, with a record monthly sales of over 30,000 units in December [3] - Lynk & Co maintained strong growth with annual sales of 350,000 units, a 23% increase [5] New Energy and Technological Advancements - Geely Galaxy became a significant growth driver, achieving 1.24 million units in sales, a 150% increase [7] - The company launched the first full-domain AI technology system in the industry, marking a significant milestone in its smart and electric vehicle strategy [10] - Geely's advancements in battery technology include the ShenDun battery with industry-leading safety and fast-charging capabilities [14] Global Expansion and Market Penetration - Geely's overseas sales reached 420,000 units in 2025, with over 120,000 units being new energy vehicles, reflecting a strong global competitive advantage [17] - The brand entered 13 new markets in 2025, expanding its presence in Europe and high-potential markets in South America and Africa [19] - Geely's localization efforts included the launch of a CKD factory in Egypt and the production of new energy vehicles in Indonesia [20] Environmental, Social, and Governance (ESG) Initiatives - Geely was included in the S&P Global "Sustainability Yearbook 2026," being the only Chinese automaker among 88 selected manufacturers [22] - The company achieved a 25.5% reduction in carbon emissions per vehicle compared to 2020, exceeding its carbon reduction targets [22] - Geely continues to lead in ESG rankings, being recognized as the top Asian automaker in the Lead the Charge automotive supply chain ESG ranking [22]

格隆汇3月19日丨友邦保险(01299.HK)公布截至2025年12月31日止年度的财务业绩，新业务价值上升 15%至55.16亿美元；内涵价值营运回报达15.8%，上升90个基点；内涵价值权益为797亿美元，按实质 汇率基准计算，每股增加14%。报告期内，税后营运溢利为71.36亿美元，每股增加12%；每股税后营运 溢利自2023年至2026年的复合年均增长率目标为9%至11%，对实现或超越此目标充满信心；股东分配 权益营运回报达15.5%，上升70个基点。 报告期内，产生的基本自由盈余达67.65亿美元，每股上升11%；扣除新业务投资后，产生的自由盈余 净额每股上升14%至44.51亿美元。截至2025年12月31日的股东资本比率为221%。末期股息上升10%至 每股144.08港仙，全年股息达每股193.08港仙，上升10%。此外，宣布新一轮17亿美元股份回购。 友邦保险集团首席执行官兼总裁李源祥表示："友邦保险在2025年业绩创新高，新业务价值、盈利及现 金流产生等主要财务指标均录得双位数增长。增长基础广泛，带动新业务价值上升15%，明确展现出我 们业务的实力和多元化优势。扣除股息及股份回购后，内涵价 ...

Core Viewpoint - The company Kolon Biotech announced that the final analysis results of the overall survival (OS) from the OptiTROP-Lung03 clinical study of its antibody-drug conjugate (ADC) sac-TMT will be presented at the 2026 European Lung Cancer Conference (ELCC) in Copenhagen from March 25 to 28, 2026, with the study's abstract published in ESMO Open [1] Group 1 - The OptiTROP-Lung03 study aims to evaluate the efficacy and safety of sac-TMT monotherapy (5 mg/kg every two weeks) compared to docetaxel in patients with locally advanced or metastatic EGFR-mutant non-small cell lung cancer (NSCLC) who have previously received EGFR-TKI and platinum-based chemotherapy [2] - Results presented at the 2025 American Society of Clinical Oncology (ASCO) annual meeting showed that among 137 randomized patients, sac-TMT demonstrated significant statistical and clinical improvements in progression-free survival (PFS) and OS compared to docetaxel, with a PFS hazard ratio (HR) of 0.30 (95% CI: 0.20–0.46, one-sided p<0.001) and an OS HR of 0.49 (95% CI: 0.27–0.88, one-sided p=0.007) [2] - Based on these positive results, sac-TMT received approval from the National Medical Products Administration (NMPA) for this indication, which has been included in the national medical insurance catalog [2] Group 2 - The 2026 ELCC will present the final analysis results of the OS from the OptiTROP-Lung03 study, along with updated PFS data, with a median follow-up time of 23.8 months as of December 11, 2025 [3] - In the docetaxel treatment control group, 41.3% of patients chose to receive subsequent sac-TMT treatment after disease progression. The median OS for the sac-TMT group was 20.0 months compared to 11.2 months for the docetaxel group (HR 0.45, 95% CI: 0.28–0.73), with 18-month OS rates of 54.7% vs 9.1% [3] - If the OS of the control group is not adjusted for subsequent sac-TMT treatment, the median OS for the two groups would be 20.0 months vs 13.5 months (HR 0.63, 95% CI: 0.40–0.98). The investigator-assessed median PFS was 7.9 months vs 2.8 months (HR 0.23, 95% CI: 0.15–0.35) [3]